Related Experiment Videos
[Double-blind comparative study between difluocortolone-valerianate and fluocinolone-acetonide ointments]
La Prensa Medica Mexicana
|March 1, 1977
Summary
Nerisone cream, containing diflucortolon valerate, showed potential superiority over fluocinolon-acetate in a double-blind trial. This clinical comparison involved 30 patients evaluating topical corticosteroid efficacy.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Topical corticosteroids are mainstays in treating inflammatory skin conditions.
- Comparing the efficacy of different corticosteroid formulations is crucial for optimizing patient care.
Purpose of the Study:
- To conduct a double-blind clinical comparison between Nerisone cream (diflucortolon valerate 0.1%) and fluocinolon-acetate.
- To evaluate the relative efficacy and potential superiority of Nerisone cream.
Main Methods:
- A double-blind clinical trial was performed.
- The study included 30 patients with dermatological conditions requiring topical corticosteroid treatment.
- Nerisone cream was directly compared against fluocinolon-acetate.
Main Results:
- The clinical trial results suggest a potential superiority of Nerisone cream.
- Despite minor variations, the data favored Nerisone cream over fluocinolon-acetate.
Conclusions:
- Nerisone cream (diflucortolon valerate 0.1%) may offer advantages compared to fluocinolon-acetate.
- Further investigation could solidify the observed superiority in clinical practice.